Canali, L.; Gaino, F.; Valenziano, C.; Sandri, G.; Paderno, A.; Ferreli, F.; Malvezzi, L.; Mazziotti, G.; Lania, A.; Spriano, G.;
et al. Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma. J. Clin. Med. 2026, 15, 2363.
https://doi.org/10.3390/jcm15062363
AMA Style
Canali L, Gaino F, Valenziano C, Sandri G, Paderno A, Ferreli F, Malvezzi L, Mazziotti G, Lania A, Spriano G,
et al. Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma. Journal of Clinical Medicine. 2026; 15(6):2363.
https://doi.org/10.3390/jcm15062363
Chicago/Turabian Style
Canali, Luca, Francesca Gaino, Claudia Valenziano, Giulio Sandri, Alberto Paderno, Fabio Ferreli, Luca Malvezzi, Gherardo Mazziotti, Andrea Lania, Giuseppe Spriano,
and et al. 2026. "Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma" Journal of Clinical Medicine 15, no. 6: 2363.
https://doi.org/10.3390/jcm15062363
APA Style
Canali, L., Gaino, F., Valenziano, C., Sandri, G., Paderno, A., Ferreli, F., Malvezzi, L., Mazziotti, G., Lania, A., Spriano, G., & Mercante, G.
(2026). Monocyte-to-Lymphocyte Ratio as New Prognostic Factor in Patients with Medullary Thyroid Carcinoma. Journal of Clinical Medicine, 15(6), 2363.
https://doi.org/10.3390/jcm15062363
